From: Development and validation of stability-indicating UPLC method for the determination of gliclazide and its impurities in pharmaceutical dosage forms
% Level
Sample no.
% Recovery
Mean % recovery
% RSD
50
1
97.8
2
98.2
98.0
0.29
3
100
98.8
98.3
0.36
97.9
150
97.6
97.7
0.07